I

Inter Pharma PCL
SET:IP

Watchlist Manager
Inter Pharma PCL
SET:IP
Watchlist
Price: 3.78 THB -4.55% Market Closed
Market Cap: 2.3B THB
Have any thoughts about
Inter Pharma PCL?
Write Note

Inter Pharma PCL
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Inter Pharma PCL
Cost of Revenue Peer Comparison

Comparables:
D
DDD
T
TNR
K
KAMART
A
APCO
D
DOD

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
I
Inter Pharma PCL
SET:IP
Cost of Revenue
-฿1.1B
CAGR 3-Years
-83%
CAGR 5-Years
-55%
CAGR 10-Years
N/A
D
Do Day Dream PCL
SET:DDD
Cost of Revenue
-฿636.9m
CAGR 3-Years
1%
CAGR 5-Years
-16%
CAGR 10-Years
N/A
T
Thai Nippon Rubber Industry PCL
SET:TNR
Cost of Revenue
-฿1.4B
CAGR 3-Years
-1%
CAGR 5-Years
-2%
CAGR 10-Years
N/A
K
Karmarts PCL
SET:KAMART
Cost of Revenue
-฿1.3B
CAGR 3-Years
-25%
CAGR 5-Years
-13%
CAGR 10-Years
-11%
A
Asian Phytoceuticals PCL
SET:APCO
Cost of Revenue
-฿50.3m
CAGR 3-Years
0%
CAGR 5-Years
4%
CAGR 10-Years
3%
D
DOD Biotech PCL
SET:DOD
Cost of Revenue
-฿472.3m
CAGR 3-Years
13%
CAGR 5-Years
-19%
CAGR 10-Years
N/A

See Also

What is Inter Pharma PCL's Cost of Revenue?
Cost of Revenue
-1.1B THB

Based on the financial report for Dec 31, 2023, Inter Pharma PCL's Cost of Revenue amounts to -1.1B THB.

What is Inter Pharma PCL's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-55%

Over the last year, the Cost of Revenue growth was -24%. The average annual Cost of Revenue growth rates for Inter Pharma PCL have been -83% over the past three years , -55% over the past five years .

Back to Top